Unknown

Dataset Information

Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings-A French Real-world Study.


ABSTRACT:

Background

This study describes the conditions of use of ceftolozane/tazobactam (C/T) and associated outcomes in French hospital settings.

Methods

This was a prospective, multicenter, French observational study. Patients who received at least 1 dose of C/T were included and followed up as per routine clinical practice, until stop of C/T.

Results

A total of 260 patients were enrolled between October 2018 and December 2019 in 30 centers across France. Of these, 177 (68.0%) received C/T as per indication of usage following the results of the antibiogram (documented cases). Among documented patients, the mean age was 61.8 years, 73.4% were males, and 93.8% presented with multidrug-resistant (MDR) bacteria at inclusion. C/T was most frequently prescribed for pneumonia (48.

SUBMITTER: Timsit JF 

PROVIDER: S-EPMC10883286 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature